Header Logo

Connection

Phoebe Moore to Male

This is a "connection" page, showing publications Phoebe Moore has written about Male.
Connection Strength

0.119
  1. Moore PS, Mokrova I, Frazier JA, Joseph RM, Santos HP, Dvir Y, Hooper SR, O'Shea TM, Douglass LM, Kuban KCK. Anxiety and Depression Correlates at Age 10 in Children Born Extremely Preterm. J Pediatr Psychol. 2021 04 16; 46(4):422-432.
    View in: PubMed
    Score: 0.044
  2. Flessner CA, Woods DW, Franklin ME, Keuthen NJ, Piacentini J, Cashin SE, Moore PS. The Milwaukee Inventory for Styles of Trichotillomania-Child Version (MIST-C): initial development and psychometric properties. Behav Modif. 2007 Nov; 31(6):896-918.
    View in: PubMed
    Score: 0.017
  3. Moore PS, Whaley SE, Sigman M. Interactions between mothers and children: impacts of maternal and child anxiety. J Abnorm Psychol. 2004 Aug; 113(3):471-6.
    View in: PubMed
    Score: 0.014
  4. Dvir Y, Frazier JA, Joseph RM, Mokrova I, Moore PS, O'Shea TM, Hooper SR, Santos HP, Kuban K. Psychiatric Symptoms: Prevalence, Co-occurrence, and Functioning Among Extremely Low Gestational Age Newborns at Age 10 Years. J Dev Behav Pediatr. 2019 12; 40(9):725-734.
    View in: PubMed
    Score: 0.010
  5. Franklin ME, Sapyta J, Freeman JB, Khanna M, Compton S, Almirall D, Moore P, Choate-Summers M, Garcia A, Edson AL, Foa EB, March JS. Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial. JAMA. 2011 Sep 21; 306(11):1224-32.
    View in: PubMed
    Score: 0.006
  6. Garcia AM, Sapyta JJ, Moore PS, Freeman JB, Franklin ME, March JS, Foa EB. Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I). J Am Acad Child Adolesc Psychiatry. 2010 Oct; 49(10):1024-33; quiz 1086.
    View in: PubMed
    Score: 0.005
  7. Lewin AB, Piacentini J, Flessner CA, Woods DW, Franklin ME, Keuthen NJ, Moore P, Khanna M, March JS, Stein DJ. Depression, anxiety, and functional impairment in children with trichotillomania. Depress Anxiety. 2009; 26(6):521-7.
    View in: PubMed
    Score: 0.005
  8. Franklin ME, Flessner CA, Woods DW, Keuthen NJ, Piacentini JC, Moore P, Stein DJ, Cohen SB, Wilson MA. The child and adolescent trichotillomania impact project: descriptive psychopathology, comorbidity, functional impairment, and treatment utilization. J Dev Behav Pediatr. 2008 Dec; 29(6):493-500.
    View in: PubMed
    Score: 0.005
  9. Tolin DF, Diefenbach GJ, Flessner CA, Franklin ME, Keuthen NJ, Moore P, Piacentini J, Stein DJ, Woods DW. The trichotillomania scale for children: development and validation. Child Psychiatry Hum Dev. 2008 Sep; 39(3):331-49.
    View in: PubMed
    Score: 0.004
  10. March JS, Franklin ME, Leonard H, Garcia A, Moore P, Freeman J, Foa E. Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder. Biol Psychiatry. 2007 Feb 01; 61(3):344-7.
    View in: PubMed
    Score: 0.004
  11. Thienemann M, Moore P, Tompkins K. A parent-only group intervention for children with anxiety disorders: pilot study. J Am Acad Child Adolesc Psychiatry. 2006 Jan; 45(1):37-46.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.